Clinical Trials · NCT05924256
A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Fudan University
- Enrollment
- 88
- Start date
- Jul 2023
- Locations
- 1 site, China
- Primary endpoint
- ORR